Biosimilars Gain Ground in Europe

May 7, 2012, 03:00 AM by Michael Croft

Forbes | Thanks to enabling legislation and differing clinical trials requirements, Europe moves further ahead in biosimilar sales.

May 7, 2012 | Thanks to enabling legislation and differing clinical trials requirements, Europe moves further ahead in biosimilar sales, with some US companies enjoying strong sales from biosimilars sold on the European market. Forbes